Arcturus Therapeutics Holdings Inc
ARCT
Company Profile
Business description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
Contact
10628 Science Center Drive
Suite 250
San DiegoCA92121
USAT: +1 858 900-2660
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
176
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,456.20 | 90.50 | 1.08% |
| CAC 40 | 7,747.99 | 154.12 | 2.03% |
| DAX 40 | 23,007.80 | 510.82 | 2.27% |
| Dow JONES (US) | 41,206.15 | 453.19 | 1.11% |
| FTSE 100 | 8,595.64 | 98.84 | 1.16% |
| HKSE | 22,504.68 | 385.27 | 1.74% |
| NASDAQ | 17,896.17 | 185.43 | 1.05% |
| Nikkei 225 | 36,830.69 | 378.39 | 1.04% |
| NZX 50 Index | 12,327.89 | 179.29 | 1.48% |
| S&P 500 | 5,668.02 | 63.88 | 1.14% |
| S&P/ASX 200 | 8,238.00 | 92.40 | 1.13% |
| SSE Composite Index | 3,279.03 | 7.62 | -0.23% |